CORTのPER（株価収益率）は？

CORCEPT THERAPEUTICS INCORPORATED（CORT）は現在PER 148.56倍で取引されています。

CORTのROE（自己資本利益率）は？

CORCEPT THERAPEUTICS INCORPORATEDのROEは7.78%です。

CORTの配当利回りは？

CORCEPT THERAPEUTICS INCORPORATEDの配当利回りは0.00%です。

CORTの品質スコア（Quality Score）は？

当社のAIはCORTの総合財務品質を100点中31点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

CORTは今が買い時ですか？

当社AIのタイミングスコアは100点中91点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

CORTはどのセクターに属しますか？

CORCEPT THERAPEUTICS INCORPORATEDはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

CORT (NASDAQ) 株価分析 | CORCEPT THERAPEUTICS INCORPORATED

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-06-30)

CORT AI Analysis Summary

Our AI summary for CORT: CORCEPT THERAPEUTICS INCORPORATED (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 148.56, ROE of 7.78%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

CORT

CORCEPT THERAPEUTICS INCORPORATED

US:NASDAQ STOCK Healthcare >> Biotechnology News 96

USD 114.49

-3.83 (-3.24%) Day Change

Watchlist Portfolio Compare Chart

148.56

P/E

0.00

D/E

7.8%

ROE

6.2%

ROA

0.00%

Div Yield

78.19

PEG

CORCEPT THERAPEUTICS INCORPORATED
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 114.49 Price -3.83 (-3.24%) Day Change	NEWS SCORE: 96

CORT, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) but テクニカルスコアは ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: P/Eが高い。割高銘柄。
ROEが低い
ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAの伸びが低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Deepscope 分析

44%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	96
Magic Formula Rank by ROA	1904
Magic Formula Rank by ROE	1904
Magic Formula Rank by ROIC	2288
Price	114.49
PBV / Sector	18.12 / 5.20
Earning Per Share	0.49

PE / Sector	148.56 / 19.97
PEG or PE/Growth / Sector	78.19 / 1.22
Average 1M Daily Value	130.18 M GREAT
Average 1W Daily Value	210.94 M GREAT

Timing Factors

100%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

58%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	6.61 / 98.71
NPM Average (%) / Sector	17.53 / -1,721.76 GREAT
NPM Change Average (%) / Sector	-26.26 / 5,211.62
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	6.18 / 27.02
ROA Average (%) / Sector	13.83 / -368.17
ROA Change Average (%) / Sector	-20.23 / 5,404.12
ROE (%) / Sector	7.78 / 3.47
ROE Average (%) / Sector	16.98 / 6.51
ROE Change Average (%) / Sector	-18.20 / 2,128.13
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

登録情報

Analyze Date	2026-08-01 07:59:40
Symbol	CORT
Name	CORCEPT THERAPEUTICS INCORPORATED
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	108.10 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	12,790.20 / 9,903.94

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 101 Redwood Shores Parkway, Redwood City, CA, United States, 94065

Phone: 650 327 3270

Website: https://www.corcept.com

Employees: 730

Sector: Healthcare >> Biotechnology

Description: Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers Korlym, an oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. It also develops relacorilant, a selective cortisol modulator for patients with hypercortisolism; a selective cortisol modulator miricorilant, which is in Phase 1b trial for metabolic dysfunction-associated steatohepatitis; and a portfolio of proprietary selective cortisol modulators, such as relacorilant, nenocorilant, miricorilant, and dazucorilant for the treatment of Lou Gehrig's disease. The company was incorporated in 1998 and is headquartered in Redwood City, California.